1440 related articles for article (PubMed ID: 23886000)
1. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
3. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
4. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
7. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.
Andrei G; Snoeck R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672709
[TBL] [Abstract][Full Text] [Related]
8. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
9. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
11. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus: review of its management.
Mustafa MB; Arduino PG; Porter SR
J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461
[TBL] [Abstract][Full Text] [Related]
13. FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?
De Clercq E
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458500
[TBL] [Abstract][Full Text] [Related]
14. Varicella zoster virus. Recent advances in management.
Rajan P; Rivers JK
Can Fam Physician; 2001 Nov; 47():2299-304. PubMed ID: 11768928
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
16. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
17. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
18. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster: an update on current treatment options and future perspectives.
Kim SR; Khan F; Ramirez-Fort MK; Downing C; Tyring SK
Expert Opin Pharmacother; 2014 Jan; 15(1):61-71. PubMed ID: 24289750
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
Freer G; Pistello M
New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]